Overview

Literature surveillance is an important tool in pharmacovigilance monitoring to ensure the safety and efficacy of products from clinical development stage through post-marketing. Research professionals face an increasingly complicated task due to the heightened level of scrutiny combined with the likelihood of high volumes of information from heterogeneous data sources.

Join this webinar with ICON and Oracle

Register today

Key Learning Objectives:

  • Developing an adequate literature search strategy in support of regulatory compliance.
  • Monitoring safety cases for diverse drug portfolios.
  • The risk of conducting literature reviews manually.
  • Identifying rare adverse events surveilling literature.
  • Leveraging automation and standardised processes to streamline literature surveillance.

Speakers:

Andrew Purchase

Director of Pharmacovigilance Specialized Services and UK QPPV at ICON

Michael Braun-Boghos

Senior Director of Safety Strategy at Oracle Life Sciences

Moderated by Peter O’Blenis

CEO at DistillerSR